Bonus Episode | 18 MAY 2021
Emerging Immunotherapies for Patients with Myelodysplastic Syndrome
This episode, sponsored by Novartis, is a discussion around myelodysplastic syndrome (MDS). Dr Esther Natalie Oliva, Great Metropolitan Hospital BMM, Italy, and Dr David Valcárcel, Vall d’Hebron University Hospital, Spain, elucidate on data regarding immunotherapy for the treatment of patients living with MDS from the recent European School of Haematology (ESH) 7th Translational Research Conference.
Download MP3 (mp3, 28:54 mins)
